LOINC Panel Details

Panel: 45270-6 - Acute leukemia Pnl Spec FC

• 45270-6 - Acute leukemia Pnl Spec FC (Seq: 787, Type: Question, expects user entry) None
  • 26563-7 - CD1a Cells NFr Spec (Seq: 1, Type: Question, expects user entry) %

    Required: O
  • 20594-8 - CD2 Cells NFr Spec (Seq: 2, Type: Question, expects user entry) %

    Required: R
  • 20599-7 - CD3 Cells NFr Spec (Seq: 3, Type: Question, expects user entry) %

    Required: R
  • 32516-7 - CD3+CD4+ Cells NFr Spec (Seq: 4, Type: N/A) %

    Required: O
  • 20611-0 - CD5 Cells NFr Spec (Seq: 5, Type: Question, expects user entry) %

    Required: O
  • 20612-8 - CD7 Cells NFr Spec (Seq: 6, Type: Question, expects user entry) %

    Required: R
  • 32518-3 - CD3+CD8+ Cells NFr Spec (Seq: 7, Type: N/A) %

    Required: O
  • 20587-2 - CD10 Cells NFr Spec (Seq: 8, Type: Question, expects user entry) %

    Required: R
  • 20588-0 - CD13 Cells NFr Spec (Seq: 9, Type: Question, expects user entry) %

    Required: R
  • 20589-8 - CD14 Cells NFr Spec (Seq: 10, Type: Question, expects user entry) %

    Required: R
  • 32758-5 - CD11b Cells NFr Spec (Seq: 11, Type: Question, expects user entry) %

    Required: O
  • 21154-0 - CD11c Cells NFr Spec (Seq: 12, Type: Question, expects user entry) %

    Required: O
  • 20590-6 - CD15 Cells NFr Spec (Seq: 13, Type: Question, expects user entry) %

    Required: O
  • 20593-0 - CD19 Cells NFr Spec (Seq: 14, Type: Question, expects user entry) %

    Required: R
  • 20595-5 - CD20 Cells NFr Spec (Seq: 15, Type: Question, expects user entry) %

    Required: O
  • 20601-1 - CD33 Cells NFr Spec (Seq: 16, Type: Question, expects user entry) %

    Required: R
  • 20602-9 - CD34 Cells NFr Spec (Seq: 17, Type: Question, expects user entry) %

    Required: R
  • 20603-7 - CD38 Cells NFr Spec (Seq: 18, Type: Question, expects user entry) %

    Required: O
  • 20608-6 - CD41 Cells NFr Spec (Seq: 19, Type: Question, expects user entry) %

    Required: O
  • 33775-8 - CD41a Cells NFr Spec (Seq: 20, Type: Question, expects user entry) %

    Required: O
  • 20610-2 - CD45 Cells NFr Spec (Seq: 21, Type: Question, expects user entry) %

    Required: R
  • 21166-4 - CD56 Cells NFr Spec (Seq: 22, Type: Question, expects user entry) %

    Required: O
  • 32747-8 - CD64 Cells NFr Spec (Seq: 23, Type: Question, expects user entry) %

    Required: O
  • 21169-8 - CD71 Cells NFr Spec (Seq: 24, Type: Question, expects user entry) %

    Required: O
  • 42933-2 - CD79a Cells NFr Spec (Seq: 25, Type: Question, expects user entry) %

    Required: O
  • 32742-9 - CD117 Cells NFr Spec (Seq: 26, Type: Question, expects user entry) %

    Required: R
  • 32750-2 - CD235a Cells NFr Spec (Seq: 27, Type: Question, expects user entry) %

    Required: O
  • 32751-0 - HLA-DR+ Cells NFr Spec (Seq: 28, Type: Question, expects user entry) %

    Required: R
  • 20617-7 - Lymphs Kappa/lymph NFr Spec (Seq: 29, Type: Question, expects user entry) %

    Required: O
  • 20618-5 - Lymphs Lambda/lymph NFr Spec (Seq: 30, Type: Question, expects user entry) %

    Required: O
  • 32759-3 - Myeloperoxidase Cells NFr Spec (Seq: 31, Type: Question, expects user entry) %

    Required: O
  • 38435-4 - TdT Cells NFr Spec (Seq: 32, Type: Question, expects user entry) %

    Required: O
  • 45267-2 - Acute leukemia markers Spec-Imp (Seq: 33, Type: Question, expects user entry) None

    Required: O
  • 49312-2 - Acute leukemia markers Spec-Imp (Seq: 34, Type: Question, expects user entry) None

    Required: O